Stockscreener 앱 받기
3.50
2.94%
0.10
시간 외 거래:
3.47
-0.03
-0.86%
전일 마감가:
$3.40
열려 있는:
$3.42
하루 거래량:
41,623
Relative Volume:
0.77
시가총액:
$8.91M
수익:
$5.51M
순이익/손실:
$-6.16M
주가수익비율:
-9.4595
EPS:
-0.37
순현금흐름:
$-5.03M
1주 성능:
+15.51%
1개월 성능:
+10.76%
6개월 성능:
-27.08%
1년 성능:
+31.54%
1일 변동 폭
$3.42
$3.56
1주일 범위
$2.94
$3.56
52주 변동 폭
$1.932
$10.16
Biomerica Inc Stock (BMRA) Company Profile
명칭
Biomerica Inc
전화
(949) 379-2875
주소
17571 VON KARMAN AVENUE, IRVINE, CA
BMRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
3.50 | 7.71M | 5.51M | -6.16M | -5.03M | -0.37 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-11-10 | 개시 | Colliers Securities | Buy |
| 2018-01-04 | 개시 | B. Riley FBR, Inc. | Buy |
Biomerica Inc 주식(BMRA)의 최신 뉴스
What analysts say about Biomerica Inc. stockExplosive wealth accumulation - Autocar Professional
Published on: 2025-07-20 03:50:26 - jammulinksnews.com
Is Biomerica Inc. a good long term investmentExceptional trading results - jammulinksnews.com
What drives Biomerica Inc. stock priceJaw-dropping returns - Jammu Links News
Biomerica Inc. Stock Analysis and ForecastTriple-digit returns - jammulinksnews.com
Is Biomerica Inc. stock overhyped or has real potentialFree Investment Community - Newser
How Biomerica Inc. stock performs during market volatilityTrend Based Entry Alerts - Newser
What makes Biomerica Inc. stock price move sharplyFree Investing Community - Newser
Why Biomerica Inc. stock attracts strong analyst attentionFree Stock Market Forums - Newser
Breakthrough IBS Test Secures Major Insurance Milestone: What This Means for 45M American Patients - Stock Titan
Biomerica, Inc. Secures PLA Code for inFoods® IBS Test to Enhance Patient Access and Insurance Reimbursement - Nasdaq
Biomerica Inc. Appoints Scott Madel as Chief Commercial Officer to Drive Growth of inFoods® IBS - Quiver Quantitative
Diagnostics Leader Who Drove $100M Revenue Growth Joins Biomerica to Scale IBS Testing Innovation - Stock Titan
Is Biomerica, Inc. technically bullish or bearish? - MarketsMojo
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Rises By 26.4% - Defense World
Biomerica (NASDAQ:BMRA) Stock Price Passes Below 200 Day Moving Average – What’s Next? - Defense World
Biomerica appoints Eric B. Chin to Board of Directors By Investing.com - Investing.com South Africa
Biomerica, Inc. Announces Board and Committee Changes, Effective June 4, 2025 - marketscreener.com
Biomerica appoints Eric B. Chin to Board of Directors - Investing.com Australia
Biomerica Appoints Eric B. Chin to Board - TipRanks
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair | BMRA Stock News - GuruFocus
Healthcare CFO Who Raised $60M Joins Biomerica Board to Lead Audit Committee - Stock Titan
Biomerica's inFoods IBS Clinical Study Results Published in June 2025 Issue of Gastroenterology - marketscreener.com
inFoods IBS test shows promise for IBS management - Investing.com
Biomerica (BMRA) Showcases Promising Results for inFoods IBS Tes - GuruFocus
Biomerica announces publication of data from inFoods IBS clinical study - TipRanks
Biomerica's inFoods® IBS Clinical Study Results Published in Jun - GuruFocus
Biomerica (BMRA) Showcases Promising Results for inFoods IBS Test in Clinical Trial | BMRA Stock News - GuruFocus
Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology - The Manila Times
Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology | BMRA Stock News - GuruFocus
Breakthrough IBS Treatment Shows 60% Success Rate in Major Clinical Trial, Published in Gastroenterology - Stock Titan
Biomerica announces real-world results of its inFoods IBS product - TipRanks
Biomerica (BMRA) Reports Positive Real-World Results for inFoods - GuruFocus
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System | BMRA Stock News - GuruFocus
Wall Street Backs Dell’s AI Strategy with Buy Ratings - The Globe and Mail
New IBS Treatment Cuts Pain by 49% Without Drugs: Groundbreaking Real-Time Patient Monitoring System Launches - Stock Titan
‘AI Momentum Is Real,’ Say Analysts After Google I/O 2025 - The Globe and Mail
Glass House Brands and LEEF Announce MSA for The Leaf El Paseo Dispensary and Off-Take Agreement - The Globe and Mail
Prediction: This Artificial Intelligence (AI) Semiconductor Stock Will Soar After May 28 - The Globe and Mail
Biomerica, Inc. and CLIA Laboratory Partner Filed for inFoods IBS Test - marketscreener.com
Biomerica submits application for PLA code for inFoods IBS diagnostic test - TipRanks
Biomerica (BMRA) Seeks New CPT Code for IBS Diagnostic Test | BMRA Stock News - GuruFocus
PLA Code Application Filed for inFoods IBS TestA Key Step Toward Reimbursement - The Manila Times
PLA Code Application Filed for inFoods IBS Test -- A Key Step Toward Reimbursement | BMRA Stock News - GuruFocus
PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement - TradingView
Biomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s Disappointed - MSN
Biomerica (NASDAQ:BMRA) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell? - American Banking and Market News
Biomerica announces Fortel Ulcer Test approved for sale by UAE Ministry - TipRanks
Biomerica Inc (BMRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.17%
자본화:
|
볼륨(24시간):